Ruhrlandklinik Westdeutsches Lungenzentrum Am Universitaetsklinikum Essen gGmbH

At Ruhrlandklinik Westdeutsches Lungenzentrum Am Universitaetsklinikum Essen gGmbH, much of the clinical trial activity focuses on respiratory tract diseases, especially idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, and other forms of fibrotic lung disease. These studies are designed to test new treatments, better understand lung function decline, and improve care for people living with chronic, progressive lung conditions.

• Testing new therapies for idiopathic pulmonary fibrosis and related fibrotic disorders
• Evaluating treatments for progressive pulmonary fibrosis and interstitial lung diseases
• Assessing ways to slow lung function loss and improve breathing outcomes

The site’s pulmonary team is especially active in studies aimed at improving treatment effectiveness and long-term disease control in complex lung fibrosis.

This site also supports a strong portfolio in cystic fibrosis, bronchiectasis, and infection-related airway disease. The trials explore new approaches to improving mucus clearance, reducing respiratory symptoms, and managing chronic Pseudomonas aeruginosa or nontuberculous mycobacterial infections, with the goal of making daily breathing easier and lowering the burden of long-term lung disease.

• Investigating therapies for cystic fibrosis and its complications
• Studying bronchiectasis with chronic bacterial colonization
• Evaluating treatments for persistent airway infection and symptom control

Several studies at this Essen site are focused on improving respiratory health in patients with complex, infection-prone lung conditions.

Another important research area includes asthma and chronic obstructive pulmonary disease, where trials aim to reduce exacerbations, improve control in patients with persistent symptoms, and evaluate new options for rescue or maintenance treatment. These studies are intended to help patients who remain poorly controlled despite standard care.

• Testing new treatments for uncontrolled asthma
• Evaluating approaches to reduce flare-ups in COPD
• Studying symptom control and rescue treatment effectiveness

The research reflects a broader effort in pulmonology to improve everyday symptom management and prevent worsening disease.

Clinical trials at the site also address pulmonary hypertension, particularly when it occurs alongside interstitial lung disease. These studies examine whether new inhaled or supportive therapies can improve exercise capacity, breathing performance, and overall cardiopulmonary outcomes in patients with advanced lung disease.

• Assessing therapies for pulmonary hypertension associated with interstitial lung disease
• Measuring effects on walking ability and functional status
• Exploring treatment options for complex cardiopulmonary disease

This line of research highlights the clinic’s interest in conditions where lung and heart complications overlap.

The site contributes to research in less common respiratory and immune system diseases, including pulmonary sarcoidosis, autoimmune pulmonary alveolar proteinosis, and interstitial lung disease linked to systemic autoimmune rheumatic diseases. These studies aim to improve disease understanding and identify therapies that may help patients with difficult-to-treat inflammatory lung disorders.

• Evaluating new options for pulmonary sarcoidosis
• Studying autoimmune and rheumatic disease-associated lung involvement
• Developing better treatment strategies for rare inflammatory lung conditions

Research in this area shows the site’s breadth beyond common lung disease into specialized rare disease care.

In addition to its core pulmonary portfolio, the site is involved in trials for non-small cell lung cancer and selected studies on symptoms such as cough and insomnia disorder. These projects focus on improving treatment effectiveness, reducing symptom burden, and supporting quality of life in people affected by serious chronic illness.

• Studying treatment effectiveness in resected non-small cell lung cancer
• Evaluating therapies for persistent cough in fibrotic lung disease
• Exploring options for insomnia disorder in patients with chronic respiratory conditions

These studies add a broader clinical dimension to the research profile of the Klinik für Pneumologie, combining symptom management with disease-focused care.